TAZOCIN

This brand name is authorized in Brazil, Cyprus, Ecuador, Estonia, Hong Kong, Lithuania, Malta, Mexico, New Zealand, Poland, Singapore, United Kingdom, South Africa

Active ingredients

The drug TAZOCIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Piperacillin UNII M98T69Q7HP - PIPERACILLIN SODIUM

Piperacillin is a broad-spectrum, semisynthetic penicillin. Piperacillin exerts bactericidal activity by inhibition of both septum and cell-wall synthesis. Read about Piperacillin

2 Tazobactam UNII UXA545ABTT - TAZOBACTAM SODIUM

Tazobactam is a beta-lactam structurally related to penicillins. It is an inhibitor of many molecular Class A beta-lactamases, including CTX-M, SHV, and TEM enzymes. Read about Tazobactam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TAZOCIN Powder for solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01CR05	Piperacillin and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522703401151317, 522703402156312
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29991-09-11
Country: EE	Ravimiamet	Identifier(s): 1130713, 1160648, 1605530, 1605541, 1605552, 1698936
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 44377, 44380
Country: HK	Department of Health Drug Office	Identifier(s): 49703, 58094
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015512, 1021008, 1063716, 1063717, 1063719, 1079231
Country: MT	Medicines Authority	Identifier(s): MA505/06001, MA505/06002
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 192M2015
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6455
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100065887, 100065893
Country: SG	Health Sciences Authority	Identifier(s): 08362P
Country: ZA	Health Products Regulatory Authority	Identifier(s): Z/20.1.1/201